◆ 会议时间：2026年6月8-13日
◆ 会议地点：法国 多维尔（Deauville）

◆ 会议简介：

2026年第64届粒子治疗协作组(PTCOG)年会将于2026年6月8-13日在法国多维尔举行，PTCOG年会是粒子治疗领域首屈一指的聚焦前沿科学、技术 和临床应用的科学会议，预计将有超过1000名来自世界各地的专业人士与会，与会者包括医生、物理学家、生物学家、基础科学家、护士、放射治疗师，剂量师，管理人员和行业专业人士等等。

国际粒子治疗协作委员会(PTCOG)成立于1985年，是一个由对质子、轻离子和重带电粒子放射治疗感兴超的科学家和专业人士组成的非营利性国际组织。PTCOG的使命是促进粒子治疗的科学、技术和实际临床应用，最终目标宣是最终目标是在放射疗法中尽可能提高癌症治疗水平。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

PTCOT 64- 634th Annual Conference of the Particle Therapy Co-Operative Group

Dates:
8–13 June 2026

Venue:
Deauville, Normandy France

摘要征文投稿：

Abstract Submission Deadline: Tuesday, 13 January 2026 - 23:59 CET

点此提交摘要>>>Submit Abstract>>>

• View the Abstract Topics

RULES FOR SUBMISSION

Please read the submission rules before submitting an abstract.

• Abstracts must be submitted online via the website only.
  ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Presentation Type: Abstracts may be submitted for oral or e-poster presentation.
  The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• Limitations:
• An individual may be listed as the presenting author on one abstract only.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by 6 April 2026 will be scheduled for presentation and included for publication.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Conference publications.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• Previously Presented/Published Policy:
  
  • Abstracts must be original and must not be or have been published or presented at any other meeting prior to the Conference. Abstracts containing updated information or modified data to previously published or presented abstracts will not be considered or accepted for presentation.
• Abstracts must be submitted in English.
• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

GUIDELINES FOR SUBMISSION

Before you begin, please prepare the following information:

• Presenting author’s contact details:
  -Full first and family name(s)
  – Email address
  – Affiliation details: department, institution / hospital, city, state (if relevant), country
  – Phone number
• Author and co-authors’ details (up to 20 co-authors allowed)
• Preferred Presentation type: Oral or E-Poster
• Abstract title – must be in sentence case and limited to 20 words. Please submit symbols as words.
• Abstract text – limited to 350 words including acknowledgements. Please note: word count is affected when tables are included.
• Abstract topic– select the abstract topic per the list of topics.
• Images– The maximum file size of each image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload images in JPG, GIF or PNG format. You may upload up to 2 images / tables
• Abstracts should clearly state:
  Background and aims
  Methods
  Results
  Conclusions  
• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers or other identifying information.
• The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline if not submitted, drafts will be deleted.
• Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
• You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.

PTCOG ABSTRACT AWARDS

During each annual conference, PTCOG recognizes and awards the research of multiple abstract authors. There are 3 award opportunities connected to PTCOG 63 as follows:

Micheal Goitein Awards:

In memory of one of the true pioneers in Particle Therapy, 3 Micheal Goitein awards are presented within the PTCOG 64 Networking Reception for the ‘Best Abstract Award’. One award per discipline of Physics, Radiation Biology and Clinics are selected from the peer review and additional review from the PTCOG Scientific Program Sub-Committee and Executive Committee. Awards are presented to award winners in the form of a personalized engraved plaque. Winners also receive a free ticket to The PTCOG 64 Networking Reception, promotion on the PTCOG website and social media and a photo opportunity with the PTCOG President and or executive members.

Young Investigator Award:

One lucky young researcher will receive the PTCOG Young Investigator Award. The winning abstract is selected from the peer review and additional review from the PTCOG Scientific Program Sub-Committee and Executive Committee. Presentation of the award is part of the PTCOG 64 Networking Reception. The winner receives a free ticket to The PTCOG 64 Networking Reception
and promotion on the PTCOG website and social media and a photo opportunity with the PTCOG President and or executive members.

Application for the PTCOG Young Investigator Award should be completed as part of the abstract submission and you will be prompted about this during abstract submission. Candidates must meet all the following criteria:

• Completed a relevant degree (bachelor, master or Ph.D.) or concluded post-graduate clinical training, whichever date is later, within the past 5 years.
• A rank up to and including Assistant Professor, if applicable.
• Previously not been awarded a Young Investigator Award from PTCOG.

PTCOG Best Poster Award:

3 separate awards for the best poster in Physics, Radiation Biology and Clinics are selected by the PTCOG Scientific Program Sub-Committee during the annual conference. The presentation of the award is part of the PTCOG 64 Closing Ceremony. No application is necessary, and the winner receives a personalized certificate signed by PTCOG Executives, promotion on the PTCOG website and social media and a photo opportunity with the PTCOG President and or executive members.

ABSTRACT SUBMITTERS’ DECLARATION

During abstract submission you will be asked to confirm that you agree to the following:

1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
2. Submission of the abstract constitutes the consent of all authors to publication (e.g. Conference website, programs, other promotions, etc.)
3. The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to PTCOG and Kenes International Organizers of Congresses SA and its affiliates (together: the “Organizers“), nor the publication of any such Content by each of the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
4. The Abstract Submitter grants each of the Organizers the license and right to use, reproduce, publish, translate, distribute, and display the Content or any part thereof, in any manner and on any platform or media whatsoever, in each Organizer’s absolute discretion, on a royalty-free, perpetual, irrevocable nonexclusive basis.
5. I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
6. I understand that the presenting author must be a registered participant.
7. The Organizers reserve the right to remove from publication and/or presentation an abstract which does not comply with the above.
8. I understand that I must select a specific Theme, Topic and/or Sub-Topic for my abstract allocation. Although the Committee will work hard to honour this selection, this cannot be guaranteed.  The Committee reserves the right to change the Theme, Topic or Sub-Topic under which the abstract was originally submitted.
9. I confirm to have received the consent of all authors for the processing of their contact details by Kenes and the Organizers.

Dear Colleagues,

On behalf of the PTCOG Executive Committee and the Local Organizing Committee, it is our great pleasure to invite you to Deauville, Normandy, France, for the 64th Annual Conference of the Particle Therapy Cooperative Group (PTCOG 64), taking place from 8–13 June 2026.

Deauville, nestled along the historic and scenic Normandy coast, offers an inspiring setting to connect, collaborate, and continue to push the boundaries in the field of particle therapy. Known for its seaside charm and rich cultural heritage, this iconic French town will provide a warm and engaging backdrop for our global community.

Our theme, “Waves of Innovation: Advancing Particle Therapy Together,” celebrates the dynamic progress in our field and the shared efforts driving its future. With exciting developments in technology, clinical applications, biology, and global access, this conference will explore breakthroughs and shape the next chapter in particle therapy.

Not breaking with tradition PTCOG 64 will feature two days of educational programming, followed by three days of scientific sessions, highlighting the latest research, clinical case studies, and strategic discussions across all disciplines of particle therapy. We continue to prioritize the inclusion of early-career researchers (ECR), diverse regional perspectives, and strong engagement from our Sub-Committees community.

Whether you are a seasoned expert or new to the field, we invite you to join us in Deauville for a week of knowledge exchange, professional growth, and unforgettable experiences in one of France’s most picturesque locales.

We look forward to welcoming you to Deauville, Normandy for PTCOG 64!

Warm regards,

Marco Durante
PTCOG President

Martin Jermann
PTCOG Secretary

Jean-Louis Habrand
Local Organizing Committee (LOC)

◆ 参会对象：医生、物理学家、生物学家、基础科学家、护士、放射治疗师，剂量师，管理人员以及从事该领域研究的科学家、研究人员、企业代表等等。